Chromosomal translocations are a hallmark of cancer. Unraveling the molecular mechanism of these rare genetic events requires a clear distinction between correlative and causative risk-determinants, where technical and analytical issues can be excluded. To meet this goal, we performed in-depth analyses of publicly available genome-wide datasets. In contrast to several recent reports, we demonstrate that chromosomal translocation risk is causally unrelated to promoter stalling (Spt5), transcriptional activity, or off-targeting activity of the activation-induced cytidine deaminase. Rather, an open chromatin configuration, which is not promoter-specific, explained the elevated translocation risk of promoter regions. Furthermore, the fact that gene size directly correlates with the translocation risk in mice and human cancers further demonstrated the general irrelevance of promoter-specific activities. Interestingly, a subset of translocations observed in cancer patients likely initiates from double-strand breaks induced by an access-independent process. Together, these unexpected and novel insights are fundamental in understanding the origin of chromosome translocations and, consequently, cancer.
C
hromosomal translocations are potential cancer-initiating lesions. Despite their pathogenic risk, the fact that chromosomal translocations are rare events has hampered the analysis of the molecular mechanism underlying these genetic aberrations. Over the last decades numerous retro-and prospective studies have suggested a number of parameters and conditions that associate with the onset of chromosomal translocations. To pinpoint the mechanisms underlying these aberrations, a clear distinction between potential causal and correlative risk factors is required. Given this complexity, it is not too surprising that critical issues in the field of chromosomal translocations remain controversial, seriously hampering the field in moving forward.
One long-standing controversy relates to the association of transcription with the chromosomal translocation risk, which recently has been reconfirmed by high-throughput genome-wide translocation sequencing (HTGTS) and translocation capture sequencing (TC-Seq) (1, 2) . HTGTS and TC-Seq were both developed to study chromosome translocations at the genome level. Both next-generation sequencing (NGS) -based technologies are based on an experimental induction of a single doublestrand break (DSB) at a targeted I-SceI site by a conditionally active or a constitutively active transduced meganuclease I-SceI, respectively. These site-specific DSBs rearrange preferentially with active elements in the genome. Transcription-associated DSBs, which in accordance with the "two-break" models can provide the second DSB beyond the experimental I-SceI-induced DSBs, have been put forward as a plausible explanation for the long-standing notion that chromosomal translocations preferentially accumulate in active promoters and genes ( Fig. S1 ) (1) (2) (3) (4) (5) . However, gene access is intimately associated with gene activity and has also been associated with an increased translocation risk (6) . Thus, whether the accumulation of chromosomal rearrangements in active elements predominantly results from their increased transcriptional activity or chromatin access remains to be determined.
Possibly the most controversial concept in the translocation field relates to the actual contribution by which the activationinduced cytidine deaminase (AID) provokes chromosomal translocations. Although it is evident that AID is key in initiating somatic hypermutation and class-switch recombination of Ig genes, the extent, relevance, and frequency by which AID off-targets to non-Ig genes under physiological conditions is highly debated. AID off-target activity is proposed to range from a few genes, locating proximal to Ig genes (1, (7) (8) (9) (10) , to hundreds or even thousands of genes (11) (12) (13) (14) . In addition, a generic preference of AID to bind in promoter-proximal regions has been proposed in B cells. In ES cells, however, seemingly contradictive results suggest that AID has actually no activity in promoters, but rather has it in gene bodies (12, 13) . Although it is evident that primary and secondary Ig gene diversification is associated with DSB formation in Ig genes and chromosomal translocations, the direct contribution of RAG recombinase, encoded by the recombination activating genes (RAG1 and RAG2), or AID in the induction of DSBs at off-target sites and genome-wide translocations, however, remains controversial.
To unravel the mechanisms underlying chromosomal translocations, it is essential to distinguish between correlative and causative risk-determinants of chromosomal translocations and comprehensively integrate results obtained by different studies in a sound manner. Because of this complexity, innovative approaches are required. NGS-based genome-wide data, together
Significance
Applying innovative integrative analyses of multifactorial genome-wide data, we now demonstrate that an open chromatin configuration, which is generically enriched promoter-proximal but not promoter-specific, is the common denominator and key translocation risk-determinant of active chromatin. The finding that gene size directly correlated with its translocation risk, in both mice and cancer patients, independently emphasized the generic irrelevance of any promoter-specific activity. These data exclude activation-induced cytidine deaminase, Spt5, transcription, and promoter-proximal regions as critical risk-determinants and specific targets for genome-wide chromosomal translocations. Our insights are fundamental in understanding the origin of chromosome translocations and, consequently, cancer. with a growing database on gene fusions in human cancers, has opened unprecedented possibilities in addressing key issues related to the origins of chromosomal translocations. This report demonstrates a direct link between gene size and chromosome translocation frequency. As outlined, this finding entirely contradicts recent reports in which promoter-specific activities are defined as critical risk-determinants of chromosomal translocations. To further determine the irrelevance or relevance of single parameters within multiparameter NGS-based datasets, we established a novel paired integration analysis (PAINT), which is one of the first methods that integrates "omics" data from different origins. Our results strongly argue against a direct role of AID off-targeting, Spt5 binding in promoter-proximal regions, and transcriptional activity as critical molecular risk-determinants of genome-wide chromosomal translocations. Furthermore, open chromatin configuration rather than gene activity is identified as a relevant, biophysical riskdeterminant in facilitating chromosomal translocations in active chromatin. The identification of causal and critical risk-determinants will help to develop consensus models regarding the origin of chromosomal translocations, and thereby the origin of cancer.
Results

Chromosomal Translocations in Humans and Mice Follow the Same Gene
Size Preference. Previous HTGTS analyses, and interpretations thereof, have suggested that rearrangements preferentially accumulate proximal to the I-SceI-induced DSB. Genes in spatial proximity to a DSB are particularly prone to becoming involved in a translocation; this includes DSB-neighboring intrachromosomal genes as well as genes within interchromosomal territories (1, 9) . The size of a gene proximal to a (I-SceI-induced) DSB will unlikely be the major translocation risk-determinant, because DSB proximity tremendously increases the translocation risk of a gene. In other words, the frequency by which a proximal gene will translocate is heavily affected by its proximity to a DSB, not its size. To enable a study on translocation risk, we need to select for a group of genes for which the impact of proximity to the DSB on translocation frequency can be neglected. To accomplish this selection, we determined the number of genes with a defined number of HTGTS rearrangements and plotted those against a number of rearrangements (Fig. 1A) . This analysis revealed a steep downward gradient from intragenic to intergenic proximal (mostly intrachromosomal) and intergenic distal (mostly interchromosomal) rearrangements. In our studies on gene fusions we excluded intragenic rearrangements within the Myc locus itself (n = 66,740). Genes residing proximal to the Myc locus on chromosome 15 rearranged most frequently. This group was also comprised of Pim1, IL4ra, and Cd83 from neighboring chromosomal territories known to locate proximal to the Igh and Myc microterritories (9) . Although these proximal translocations contributed 26% of all intergenic translocations, the second group and majority of intergenic rearrangements (74%) arise distal. The subset of distal translocations allowed us to exclude the impact of proximity on chromosomal translocations and focus on the overall gene size preference of translocated genes.
To assess HTGTS as a predictive model system for chromosomal translocations that originate in human cancers, we compared the gene size distribution of interchromosomal translocated genes as observed in HTGTS (mice) to those observed in the gene fusion databases of cancer patients [cgap.nci.nih.gov/Chromosomes/ Mitelman, "Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer" (15) ]. First, all human genes were binned according their gene size, after which the fraction of 1,000 translocated genes as found in human cancer patients per bin was determined. The same was done for all mouse genes and 1,000 translocated genes as found in HTGTS. These analyses revealed that chromosome translocations in human cancers and experimentally induced in mouse model systems follow the same size distribution (Fig. 1 B and C) . This shared size preference suggested that in mice and humans, chromosomal translocations likely follow the same mechanisms that are governed by the same molecular and biophysical determinants. In addition, this analysis further validates HTGTS as an effective approach in studying rare stochastic chromosomal translocation events at an experimental high-throughput level (1).
Chromosomal Translocations Are Not Ruled by Promoter-Proximal and -Specific Activities. Although, based on gene size, HTGTS appears to be a good predictive model system for studying translocations in human cancers, the relevance of gene size for chromosome translocations in both human and mice is remarkable. This observation appears to contradict recent reports arguing for a dominant role of promoter-proximal-specific activities (AID, Spt5, transcriptional activity) as translocation risk dominators. Promoter-proximal regions are, in contrast to the gene in which they reside, of a confined size (Fig. S2 A and B) . Thus, if promoterproximal activities dominate, gene size is expected to be of minor relevance. Consequently, if promoter-specific activities rule the gene translocation risk, an accumulation of translocated genes with a median size of 9.1 (∼9,000 bp) corresponding to the normal gene size distribution is expected. However, in both mice (HTGTS) and in human, cancer-translocated genes did not accumulate at a size of 9.1 (∼9,000 bp) (15) . These analyses heavily contradict several recent publications proposing a critical role for promoter-specific activities in facilitating chromosomal translocation reactions (1, 2, 5) .
To further eliminate the possibility of promoter-specific activities as a relevant translocation risk, we theorized that if promoterspecific activities dominate the translocation risk the number of rearrangements should not relate to gene size (Fig. 1D , orange) (expected slope = 0), (Fig. 1 D and E and Fig. S2 A and B) . In contrast, if gene size directly determines the chromosome translocation risk, and promoter-specific activities basically do not contribute, an exact doubling in the median size of translocated genes is expected to double the translocation risk (expected slope = 1). If both parameters would contribute to some extent, an intermediate slope is expected to be between >0 and <1. However, a linear increase was observed where the number of rearrangements exactly doubled when doubling the gene size (Fig. 1D) , which only confirms the complete irrelevance of promoter-specific activities. The exact outcome of this unbiased calculation thereby directly disproves promoter-specific activities of any kind as prime and generic translocation risks, while simultaneously demonstrating that physical gene size directly determines the translocation risk. In this regard, gene-specific elements, like promoters or other genomic elements that do not proportionally relate to gene size, can therefore be ignored as dominating and generic translocation risks.
Transcription Does Not Contribute to Chromosomal Translocations.
There is a long-standing notion that transcriptional activity is associated with an increased risk of translocations. Because I-SceIinduced DSBs were shown to rearrange preferentially with active genomic elements, this correlation has been confirmed (1, 2). In line with the two-break translocation models, transcriptionassociated DSB formation may provide the rate-limiting secondary DSB beyond the experimentally induced I-SceI DSB (1-4, 16). However, as noted above, these measurements are correlative, and because of the intimate relation between open chromatin and gene activity, transcription is not necessarily causal for the increased translocation risk of active genomic elements (17) .
To assess if transcriptional activity is causative for translocations in promoters, in which translocations are proposed to accumulate preferentially (1), we established paired integrative (PAINT) analysis that enables determination of the relevance of a single parameter within multiparameter NGS-based datasets. First, each translocated (TL) promoter was paired to a randomly selected nontranslocated (NTL) promoter based on similarity in access, as measured by Dam profiling, where the Escherichia coli Dam methyltransferase methylates adenine within GATC sites in open chromatin configurations (Fig. S3A) . Subsequently, differences in promoter activity (ΔGRO), as measured with genomic run-on sequencing (GRO-Seq) were determined for each TL-NTL promoter pair. Finally, the median ΔGRO scores were determined. To obtain a null distribution, we repeated the same procedure but now paired randomly selected promoters (R) with randomly selected NTL-promoters of similar access. The promoter-activity of TL-NTL pairs was indistinguishable from R-NTL pairs ( Fig. 2A) . This result was independently obtained using DNase-I hypersensitivity (DHS) (1) as a measure for promoter access (Fig. 2B) . Neither of these analyses revealed an association between transcriptional activity and the likelihood of translocations in promoter regions. Remarkably, although translocations clearly accumulate within transcriptional active genomic elements, and are proposed to preferentially accumulate in promoters, these analyses strongly argued against a causal link between transcription and the accumulation of translocations.
To independently reassess the long-standing hypothesis that transcription facilitates translocations, we repeated the analyses for gene bodies. We paired each TL-gene, as determined by HTGTS, to a randomly selected NTL-gene of equal Dammethylation load and gene size. The difference in gene expression, as defined by RNA-Seq, was determined for each TL-NTL gene pair. Numerous TL-NTL pairs resulted in expression difference scores (ΔExp), and these scores were grouped on the basis of their Dam value. To obtain a reference (i.e., null distribution), we repeated the same procedure but now paired randomly selected genes (R) with randomly selected NTL-genes of similar access. The median ΔExp (R-NTL) scores appeared not to be significantly different from those of TL-NTL pairs (Fig. 2C) . A similar analysis using DHS-profiling datasets as an Log(Gene size (bp)) E Fig. 1 . Promoter-specific activities do not rule translocation risk. (A) Genes in proximity to the primary break site (Myc) are highly predisposed to become involved in a translocation reaction. Translocation events were gradient-colored (red to black), where intrachromosomal (red) were distinguished from interchromosomal (black) translocations. The number of genes with a defined number of rearrangements were grouped and plotted against the number of rearrangements. The black-to-red gradient, therefore, represents the relative contribution of intrachromosomal rearrangements to each group, where red represents rearrangements on chromosome 15 where the I-SceI-Myc site locates. A small group of previously described genes (e.g., Pim1, IL4ra, and Cd83) revalidated as residing proximal to the DSB translocate (9), but most gene fusions arise distal. This approach enables a distinction between proximal-from distal-translocation events. The distal events, as defined in this analysis, are used in HTGTS-based analyses throughout this report. The asterisk signifies that when excluding intragenic rearrangements within the Myc locus itself (n = 66740), 74% of rearrangements arise within distal genes. (B) Large genes are predisposed to become involved in a chromosome translocation. The overall gene size distribution of genes (black) and translocated genes (red) are as found by the Mitelman database. (C) Gene size distribution of chromosome translocated genes as observed in HTGTS (mice) and cancer patients. The gene size distribution of distal HTGTS translocations is represented in the red curve (n = 4,532). To enable a direct comparison of the gene size distribution of translocated genes in humans and mice (HTGTS), all human genes were binned according their gene size, after which the fraction of 1,000 translocated genes as found in human cancer patients per bin was determined (black curve). The same was done for all mouse genes and 1,000 randomly selected translocated genes as found in HTGTS (orange curve). Apparently, human and mouse chromosome translocations follow a same size distribution and, therefore, similar selection criteria. (D) Gene size directly determines the chromosome translocation risk. If promoter-specific activities dominate the translocation risk, the number of rearrangements should not relate to gene size (orange line, expected slope = 0). In contrast, if promoter-specific activities basically do not contribute, doubling the median size of translocated genes is expected to double the translocation risk (expected slope = 1). If both parameters contribute, an intermediate slope is expected (slope >0 and <1). Remarkably, and only confirming the complete irrelevance of promoter-specific and -proximal activities, a linear increase was observed where the number of rearrangements exactly doubled when doubling the gene size (black line). Distal translocated genes were binned according to rearrangement frequency and the median length was determined for each bin for both the distal Myc target genes, as obtained with HTGTS (black, n = 4,353, distal targets in C), and genes randomly selected based on their length (red, n = 4,362). The rearrangement frequency increases linearly with size. Doubling the gene size doubles the rearrangement frequency (δ 1, 2, 3). Of note, the y axis intercept does not represent a fixed size, but rather relates to the number of translocations that accumulated in this specific HTGTS study. The red line represents the expected curve if translocated genes would be selected only on the basis of their gene length (i.e., nucleotide content). (E) Gene size distribution of distal genes that rearrange with Myc. Gene size distribution of genes that rearranged one, two, three, and four times during HTGTS. Note, a peak at gene size 9 (indicative for a promoter preference) is lacking in all distributions.
independent measure for access also did not reveal transcription as relevant for translocations (Fig. 2D ). Therefore, a causal link between transcription and the accumulation of translocations in gene bodies could not be provided when correcting for accessible elements present in active genes. Taken together, these analyses imply that transcription is unlikely to link directly to translocation beyond an experimentally induced DSB (1-4, 16). Previous measurements that linked translocations to transcription likely reported a correlate.
Open Chromatin Configurations Are Predisposed for Chromosome
Translocations. Given that active genes are generically more accessible, the previous analyses suggested that it is actually the chromatin configuration rather than gene activity that is the critical risk-determinant of chromosomal translocations. To test chromatin access as a prime risk-determinant for chromosomal translocations and simultaneously exclude a potential impact of transcription on chromosomal translocations, we applied the PAINT approach. First, we matched each TL-gene to a randomly selected NTL-gene of equal expression-level score (FPKM, fragments per kilobase of transcription per million mapped reads) and gene size. Subsequently, differences in access (ΔDHS) were determined for numerous TL-NTL and R-NTL gene pairs. The TL-NTL ΔDHS values were consistently larger than R-NTL ΔDHS values (Fig. 3A) . The contribution of gene-access to the translocation risk of active genes was further assessed using Damprofiling. Again, each TL gene was coupled to a randomly selected NTL gene with equal transcriptional activity. The ΔDam medians of TL-NTL and R-NTL gene pairs were significantly elevated for TL-NTL pairs (Fig. 3B) . Similar results were obtained within promoter regions (Fig. 3 C-E) . This integrative approach revealed gene access as a key translocation risk-determinant of active chromatin.
To independently validate open chromatin as the critical riskdeterminant for translocations in genes, we grouped 50-bp microarray probes based on their Dam score. Thereafter, we determined to which gene size probes of each Dam-group preferentially reside. It appeared that most accessible genomic elements accumulated in a gene population with a median size of ∼10.9 (∼54,000 bp) (Fig.  3F ). This size matched the median size observed for the translocation partners revealed by HTGTS (10.9), whereas DSB formation modeled on the basis of nucleotide content predicted a gene population size of 12.0 (165,000 bp). This notion strongly implies that the translocation reactions involve a translocation event that directly depends on chromatin access. In accordance with the relevance of gene access as a critical translocation risk, Dam methylation accumulates in promoter-proximal regions, the region where HTGTS translocations also accumulate (Fig. S4) (1) .
Taken together, promoters and gene bodies containing elements of increased access are particularly prone to translocation. Although not promoter-specific, macromolecular DNA modification processes, as part of the underlying chromosomal translocation mechanism, favor open chromatin configuration. Hereafter we refer to these events as "access-dependent." Of note, both HTGTS and Dam-profiling revealed that accessible elements accumulate in a population of genes with a median size of 10.9 (∼54,000 bp) (Fig. 3F) .
In Human Cancers a Fraction of Translocation Events Arise AccessIndependent. Although the HTGTS experimental set-up under study showed that beyond the I-SceI-induced DSB, the ratelimiting second DSBs must arise irrespective of transcription and in an access-dependent manner, it should be taken into account that DSBs that originate under physiological conditions can also be induced by access-independent mechanisms. For example, DSBs can arise as a consequence of exposure to ionizing irradiation or other subatomic particles, ions, and electromagnetic waves, like γ-rays and X-rays. Small endogenous or exogenous DNA-damaging agents could also induce access-independent DSBs (18) . Because the initiation of these DSBs is not restricted by chromatin access, those DSBs are referred here as "accessindependent" DSBs and chromosomal translocation events (Fig.  S5) . One question that can be explored is whether those accessindependent translocation events can be part of translocation mechanisms as observed in human cancers (Fig. S5 A-D) . The median gene size in which access-independent DSBs are induced will depend considerably on the frequency at which specific gene sizes exist throughout the genome (Fig. 1B) , as well as the gene size itself (number of base pairs). As noted above, when modeling access-independent DSBs randomly throughout the genome, a population of genes with a median size of 12.0 (∼165,000 bp) was obtained (Fig. S5E) . This size clearly differs from the median gene size of 10.9 of accessible genes (i.e., access dependent genes) (∼54,000 bp) and the normal gene-size distribution, which include the overall size distribution of proximal genes, 9.1 (∼9,000 bp).
Before we use these expected access-independent size characteristics in further exploring how genes can become involved in translocations, it will be helpful to understand the effect proximity Hereafter, the difference in the GRO score was determined and subsequently binned for two independent replicates (red, TL). The same procedure was followed for randomly selected genes (gray, R). Only if translocations preferentially occur in transcribed promoters, transcriptional activity of a randomly selected promoter selected from the TL group is expected to be higher compared with a promoter selected from the NTL group (after matching both promoters on access). However, this is not the case (red). As an additional control, we also access-matched randomly picked promoters from the complete set of promoters (i.e., TLs and NTLs), with translocated promoters. This did not show a significantly (Wilcoxon test) different result from the previous analysis. (B) As in A, but now each translocated promoter was paired with a randomly selected promoter with equal DHS. Hereafter, the difference in the GRO score was determined and subsequently binned for six independent replicates (red, TL). The same procedure was followed for randomly selected genes (gray, R). (C) Each translocated gene was paired with a randomly selected gene with an equal gene size and Dam score. Subsequently, the difference in the FPKM-value of each pair was determined and binned based on their Dam score (red). The same procedure was followed for random genes (black).
(D) Each translocated gene was paired with a randomly selected gene with equal access as measured by DHS profiling. Subsequently, the difference in the transcriptional activity score (in FPKM) was determined (red, TL). The same procedure was followed for randomly selected genes (gray, R).
has on the sizes of genes that become involved in translocation. HTGTS revealed that rearrangements preferentially accumulate proximal to the I-SceI-induced DSB (Fig. 1A) . Consequently, although a DSB in a large gene will more frequently result in an intragenic rearrangement, a DSB in a small gene will more frequently result in a gene fusion (Fig. S2 C and D) . As a consequence, proximal fusions will be enriched for small genes, whereas distal fusions will be enriched for large genes. Indeed, when plotting the sum of the size of each fusion partner against the intrachromosomal distance of those partners, an increase was observed (Fig. 4A ). This increase also holds for interchromosomal rearrangements, where small genes tend to pair with small genes and large genes with large genes (Fig. 4B) . Taken together, these findings imply that distal fusions are enriched when selecting fusions that involved a large gene, and vice versa. Remarkably, the largest genes as observed in cancers tend to partner with genes of size 12.0 instead of 10.9, as would have been predicted by HTGTS. Moreover, this size distribution is entirely consistent with the predicted size 12.0 preference of accessindependent DNA damage, provoking-directly or indirectly-a DSB. The existence of this discrete size population of 12.0 was independently confirmed when considering the sizes of RUNX1 partners. RUNX1 is a large gene (14.0; i.e., 1.21 × 10 6 bp) for which 21 translocation partners are known. Those partners approximate 12.0 in size and are primarily interchromosomal translocations (18 of 21, 86%, against an overall of 60%). Taken together, these findings show that apart from the populations of fusion partners with a median gene size of 10.9, another population of 12.0 exists in human tumors, the two of which, respectively, are indicative for the existence of access-dependent and -independent translocation events underlying the origin of chromosome translocations.
AID Off-Targeting and Activity Are Confined to Ig Gene Territories.
To date, a single ChIP-Seq experiment is the only study that has claimed to have provided direct evidence for AID binding throughout the genome (∼5,900 target genes) (12) . However, this study reports differences between a condition where three immunoprecipitations (IPs) were mixed (Aicda
) and a single IP as a reference (Aicda The promoters of translocated genes are highly accessible. Each translocated promoter was paired with a randomly selected promoter with equal activity as measured by GRO-Seq. Then the difference in the DHS score was determined and subsequently binned for six independent replicates (red, TL). The same procedure was followed for randomly selected genes (gray, R). (E) As in D, but now access was determined by Dam profiling. (F) Translocation partners as identified by HTGTS are readily accessible. Nine Dam-score groups were defined and the median gene size in which these reside was determined for each group (red, 1-9) and compared with the median gene size of translocation partners as identified by HTGTS (TL, blue), as well as randomly selected genes (R, black). Accessible elements appear to accumulate in genes with a median gene size of 10.9 (∼54,000 bp).
nor specific binding of AID (Figs. S3 and S4 A-D) . In addition, independent studies performed in the laboratories of N. Papavasiliou and S. Yamanaka were also unable to validate a genome-wide AID activity in B cells and iPS, respectively (20, 21) . Furthermore, the reported HTGTS study provided by the laboratory of F. Alt proposed only a few (∼20) potential AID offtargets (1). Strikingly, having applied a normalization that takes the library compositions of Aicda −/− and Aicda +/+ into account and multiple-testing of candidate genes, only a small number of previously proposed AID targets were retrieved (Fig. S4 E and F) . These off-targets have been observed more recently by capture analyses (9) , revealing that these candidates locate in spatial proximity to Ig loci, where AID gets activated. Therefore, AID targeting and activity appears locally confined to the microterritories of Ig genes. Consequently, and entirely consistent with the exclusion of promoter-proximal activities and transcription (Figs. 1-3) , genomewide AID off-targeting and activity is irrelevant to the generation of AID-dependent chromosomal translocations (9, (22) (23) (24) (25) (26) (27) (28) (29) . In addition, the currently nonproven hypothesis of extensive AID offtargeting is heavily based on experiments comparing Aicda −/− and Aicda +/+ mice. Because developmental confounding issues exist between these conditions (19) , the option that the results obtained with Aicda −/− and Aicda +/+ mice are only indirectly related to AID or even AID-independent must be considered. Taken together, direct evidence for genome-wide binding of AID to thousands or hundreds of genes and promoters has not been provided, and independent measurements actually failed to validate AID off-targeting or a genome-wide activity (7, (19) (20) (21) . The oncogenic risk of germinal center B cells expressing AID may, with a few noted proximal exceptions, primarily relate to the DSB-inducing activity of AID in its physiological Ig targets.
Discussion
Applying deep-sequencing-based technologies (TC-Seq and HTGTS) (1, 2) generated big data on the molecular and biophysical determinants of translocation partners. Although these resources are of great scientific value to cancer research, numerous difficulties arose regarding their analyses, interpretation, and comprehensive integration with current translocation models (30, 31) . A critical reflection and reanalyses became inevitable to understand translocations in light of newly generated as well as other existing data. Both our reassessments and analyses led to much more nuanced conclusions on the relevance of AID, Spt5, transcription, chromatin configuration, and promoterspecific activities in determining the translocation risk (1, 2, 5, 6 , 12, 32, 33) (SI Text, Discussion: AID). We emphasize, that these conclusions were independently validated by our studies on the gene sizes of translocated genes as archived in the translocation databases of human cancers and the experimental HTGTS setting (1, 15; cgap.nci.nih.gov/Chromosomes/Mitelman).
Access-Dependent and -Independent Events. Based on several independent observations, we herein provide strong evidence that gene access is the critical risk-determinant for chromosomal translocations in active chromatin: (i) the PAINT analyses on transcription and access highlighted the relevance of gene access (Figs. 2 and 3) ; (ii) translocations accumulate in sonication hypersensitive sites, which are associated with access (Fig. S6) ; and (iii) the correlation between translocations and access (6) . As shown in Fig. 1C , in general the overall gene size distribution of chromosome-translocated genes follow the same size distribution and therefore the same biophysical and molecular constraints, where gene access plays a critical role for distal interchromosomal translocations (size 10.9). Therefore, access-dependent translocations that arise during HTGTS are likely to follow the same mechanism as observed for human cancers. What HTGTS misses are a minority of access-independent DSB formations and translocations. Besides gene access, our data imply that chromosomal translocations can also arise in inaccessible genes. Considering a DSB as a critical translocation-initiating event, we predicted that access-independent DSBs should predominantly arise in genes with a median gene size of 12.0 (∼165,000 bp), the most frequent gene size when considering the nucleotide content of all genes. Indeed, as predicted, besides a predominant population of accessible translocated genes of size 10.9 (∼54,000 bp) a discrete population of size 12.0 was observed for chromosome translocations in human cancers. This distinct size population strongly suggests that DSBs in inaccessible genes can also contribute to chromosome translocations. For example, oxidative and irradiation damage are likely to affect the entire genome; subsequently, two access-independent DSBs are likely to arise simultaneously, favoring translocations between otherwise inaccessible partners with a median gene size of 12.0. This scenario explains why, for example, RUNX1 has large and interchromosomal translocation partners. We conclude that the DSB initiation event likely determines the size of a translocation partner. Future discussions on chromosome translocations will have to differentiate between access-dependent and -independent translocation events and will have to consider the nature of the DSB formation itself before considering the gene size distribution of the translocation partners (17, 34, 35) .
Transcription. Transcriptional activity has long been implicated in promoting DSBs and thereby translocations (1) (2) (3) (4) (5) . However, because transcription is highly associated with open chromatin configurations, the relevance of transcription to the translocation risk is a long-standing issue. To solve this problem, we established PAINT analysis, which included independent methods of data generation. Although transcription may sporadically induce a DSB, this is beyond the measurable range in the HTGTS system. Our analyses excluded transcription as providing a second ratelimiting DSB within promoters and gene bodies. These findings highlight the analytical strength of the PAINT analysis in solving data-mining issues that arise with the correlations found between NGS-based technologies.
Promoter-Specific Activities Appear Irrelevant. The relevance of gene size, for both access-dependent and -independent processes, independently validates the irrelevance of promoter-specific activities, like Spt5 or AID binding, being dominant (i.e., measurable) in determining the translocation risk. We emphasize here that the accumulation of translocations in promoter-proximal regions was indeed measured but appeared only a consequence of accumulation-accessible elements in this region when performing a promoter alignment. However, it may be intuitive to consider this a promoter-specific preference of translocations; an enrichment of signal in a promoter alignment actually did not reflect promoterspecific activities. Therefore, in any study on translocation risk of genomic elements, it is essential to check and control for alternative explanations, as we did in our PAINT analyses for gene access.
One-or Two-Break Translocation Models vs. AID and Transcription.
Because genome-wide AID targeting in promoters (and gene bodies) has been invalidated by this study, it is worthwhile to reconsider how AID-dependent translocation can arise. Previously, AID-dependent translocation mechanisms have only been considered in the context of a two-break translocation model (1, 2, 29, (36) (37) (38) (39) . In these models AID is supposed to provide the second rate-limiting DSB besides the experimentally induced DSB at I-SceI, or under physiological conditions, the scheduled AIDinduced DSB in an IgH switch region (Fig. S7A ). Our analyses argue against a relevant role for AID as a direct genome-wide translocation risk-determinant: that is, inducer of DSBs in non-Ig genes. This notion, together with the finding that transcriptional activity also does not skew the translocation risk, revived the question of whether a second rate-limiting DSBs is necessary for a translocation to take place (34, 35) . The central question, therefore, is whether a second preexisting DSB is actually required to initiate a translocation in a nonexperimental setting and thereby in cancer. For a comprehensive integration with current translocation models, it is worthwhile to discuss AID-induced DSB at the IgH locus in the context of a one-break translocation model, where the oncogenic potential of AID primarily depends on a scheduled DSB in the IgH locus. Such a translocation-inducing (ti)DSB, that arose AID-dependent or not, will predominantly rearrange intragenic or preferentially with proximal target genes, explaining the unexpected high frequency of intragenic and proximal translocations in HTGTS. Accordingly, the defined proximal AID off-targets are indirectly targeted by the AID-induced tiDSB in the IgH locus (Fig. S7B) . This concept provides an alternative explanation on the origin of recurrent AID-dependent translocations. We emphasize that also in a two-break translocation model, AIDs oncogenic potential is largely confined to the DSB it induced in the Ig loci and the second break is most likely generated AID-independent, which is in line with many other studies implicating a high, Ig loci-specific targeting and activation of AID (1, (7) (8) (9) (10) .
Why Do Chromosomal Translocations Accumulate Promoter-Proximal?
Although not promoter-specific, it is evident that translocations accumulate promoter-proximal (1). The data described above exclude previous interpretations, where promoter-proximal activities, like AID deamination and Spt5-dependent promoter stalling, predispose chromosomal translocations in this region (Figs. 1-3) . The identification of chromatin access as a critical risk-determinant for chromosomal translocation provided a simpler but unspecific explanation for the accumulation of translocations in aligned promoters (1) (Figs. 1-3) . Although accessibility is a common feature of promoters, this feature is not promoter-specific because accessible elements are widely distributed throughout the genome. Consequently, any promoter alignment will de facto accumulate accessible elements in promoter-proximal regions. At the same time, accessible elements in gene bodies remain distributive and underrepresented. In previous studies, this confounded density profile likely suggested an increased translocation risk for promoter-proximal regions. Subsequently, this misconception put forward an inadequate coherence where promoter-proximal activities were directly linked to the origin of chromosomal translocations. We conclude that promoter-proximal activities, like those proposed for AID and Spt5, as well as promoter-proximal RNA polymerase II stalling, do not directly increase the translocation risk in HTGTS.
Concluding Remarks. The fact that different laboratories arrived at different conclusions while analyzing identical samples from raw NGS data illustrates the complexity regarding NGS-based analyses and data mining. We feel that much can be gained when experts' recommendations are being followed (30, 31, 40) (SI Text, A Guideline for Genome-Wide or Whole-Genome Approaches). This gain includes the quality control of the measurements and independent validations of the obtained results by truly separate materials and methods. To further understand the biogenesis of chromosome translocations, future studies should go beyond correlating results from independent methods. Especially in hyperaccessible regions, overlaps between different types of datasets are easily-if not always-obtained when comparing different NGS-based technologies, as often presented in Venn diagrams. In general, theorizing through frameworks of correlative results obtained with different genome-wide methods will not lead to a better understanding on the origin of chromosome translocations and, in extension, the origin of cancer. We therefore feel that the field of chromosome translocationsand mutagenesis in general-will benefit from this critical reflection and comprehensive integration of these studies. To our knowledge, the integration efforts provided in this study did not selectively exclude key concepts or neglect issues and studies in the translocation field.
Two principal modes of chromosome translocations exist (34): the one-and two-break translocation models. Although the literature suggests otherwise, we emphasize that it is currently unknown which of the two predominates in the origin of translocations observed in human cancers. Possibly in situations where a generic genome crisis occurs, for example as a consequence of access-independent ionizing irradiation or oxidative stress, two DSBs may coexist in the same cell and translocate efficiently (the two-break translocation model) (41) . Alternatively, a translocation arises as a consequence of a single tiDSB, In this onebreak translocation model, the tiDSB can arise access-dependent or -independent; HTGTS data strongly suggest that the involvement of the target element is largely determined by proximity and access. To understand which of the two mechanisms predominate the origin of translocations in cancer patients, the central question is how often two DSBs coexist in a cell and how efficient a single local DSB can induce a translocation.
Materials and Methods
PAINT Analysis. To determine the relevance of a single-parameter in multiparameter NGS-based big data requires an effective multiomics integration method. To accomplish this goal, we established PAINT analysis that enables determining the relevance of a single parameter: for example, gene access within a multiparameter NGS-based data analyses, such as gene access, gene activity, and gene size. To test, for example, chromatin access (DHS) as a riskdeterminant for chromosomal translocations and simultaneously exclude a potential impact of transcription (GRO-Seq) and gene size (base pairs) on chromosomal translocations, each known TL-gene is matched to a randomly selected NTL-gene of similar gene activity (FPKM) and gene size. In this way, two of three parameters can be excluded. To obtain a null distribution of the Δaccess, the same procedure is repeated but now a randomly selected gene is paired with a randomly selected NTL-gene of similar activity and size. Subsequently, differences in access (ΔDHS access) are determined for numerous TL-NTL and R-NTL gene pairs. Subsequently, the median ΔDHS access scores are determined for all bins containing gene pairs of similar gene activity and gene size. Although in this PAINT analysis only three parameters are compared, PAINT could, provided that the datasets are large enough, extend to multiple parameters. Next to PAINT analyses, all other analyses that are not based on PAINT are described throughout the report.
Datasets. Datasets involved in this study are as follows: RNA-Seq (GSE47705), MethylCap-Seq (GSE47704), DHS profiles, GRO-Seq (SRA049000), and HTGTS (Data S1 Sequence data). All were derived from activated B cells. Human translocations were obtained from the Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer (cgap.nci.nih.gov/ Chromosomes/Mitelman). The DAM/DamID data are accessible from the Gene Expression Omnibus (GEO) database under accession no. GSE81342 (www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE81342). The datasets were analyzed as described throughout the report using R statistical software.
